FDA Inspection 1175280 — Eurofins Pharma Quality Control

Eurofins Pharma Quality Control — FEI 3007602003

The FDA completed an inspection of Eurofins Pharma Quality Control on July 9, 2021 in Ste Croix en Plaine. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 9, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ste Croix en Plaine (France)

Additional Details

Mutual Recognition Agreement (MRA)